However, cinaciguat enhanced the activity of the cardiac PKG enzyme, and selectively inhibited pathological processes of myocardial fibrosis, nitro-oxidative stress and apoptotic cell loss. This evidence concerns the gene PRKG1 and Myocardial fibrosis.